| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Scandinavian ChemoTech AB Series B (ST: CMOTEC-B)
CMOTEC-B Technical Analysis
5
| As on 9th Sep 2025 CMOTEC-B SHARE Price closed @ 4.37 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.89 & Strong Buy for SHORT-TERM with Stoploss of 2.27 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CMOTEC-BSHARE Price
| Open | 3.77 | Change | Price | % |
| High | 4.52 | 1 Day | 0.60 | 15.92 |
| Low | 3.77 | 1 Week | 0.77 | 21.39 |
| Close | 4.37 | 1 Month | 2.14 | 95.96 |
| Volume | 183501 | 1 Year | 2.10 | 92.51 |
| 52 Week High 3.81 | 52 Week Low 1.01 | ||||
ST Sweden Most Active Stocks
| WYLD | 0.01 | 0.00% |
| LIPI | 0.22 | -4.35% |
| TERRNT-B | 0.08 | 0.00% |
| EPIS-B | 0.04 | 0.00% |
| LUNE | 21.97 | 6.65% |
| POLY | 0.04 | 0.00% |
| EURA | 0.01 | 0.00% |
| TELIA | 36.22 | 1.83% |
| AMNI | 0.01 | % |
| BIOS | 0.02 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| CMOTEC-B Daily Charts |
CMOTEC-B Intraday Charts |
Whats New @ Bazaartrend |
CMOTEC-B Free Analysis |
|
|
CMOTEC-B Important Levels Intraday
| RESISTANCE | 5.82 |
| RESISTANCE | 5.35 |
| RESISTANCE | 5.07 |
| RESISTANCE | 4.78 |
| SUPPORT | 3.96 |
| SUPPORT | 3.67 |
| SUPPORT | 3.39 |
| SUPPORT | 2.92 |
CMOTEC-B Forecast September 2025
| 4th UP Forecast | 6.49 |
| 3rd UP Forecast | 5.81 |
| 2nd UP Forecast | 5.39 |
| 1st UP Forecast | 4.97 |
| 1st DOWN Forecast | 3.77 |
| 2nd DOWN Forecast | 3.35 |
| 3rd DOWN Forecast | 2.93 |
| 4th DOWN Forecast | 2.25 |
CMOTEC-B Weekly Forecast
| 4th UP Forecast | 6.22 |
| 3rd UP Forecast | 5.63 |
| 2nd UP Forecast | 5.26 |
| 1st UP Forecast | 4.89 |
| 1st DOWN Forecast | 3.85 |
| 2nd DOWN Forecast | 3.48 |
| 3rd DOWN Forecast | 3.11 |
| 4th DOWN Forecast | 2.52 |
CMOTEC-B Forecast2025
| 4th UP Forecast | 12.31 |
| 3rd UP Forecast | 9.76 |
| 2nd UP Forecast | 8.19 |
| 1st UP Forecast | 6.62 |
| 1st DOWN Forecast | 2.12 |
| 2nd DOWN Forecast | 0.55 |
| 3rd DOWN Forecast | -1.02 |
| 4th DOWN Forecast | -3.57 |
Scandinavian ChemoTech AB Series B ( ST Sweden Symbol : CMOTEC-B )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CMOTEC-B Business Profile
Scandinavian ChemoTech AB (publ) provides cancer care and pain management solutions. Its product, IQWave, is an electroporation device, which combines short electric pulses with chemotherapy administrated locally or intravenously used for treating head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. The company markets its products through distribution channels and a network of opinion leaders in South East Asia, India, and the Philippines. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 63
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service